| Zacks Company Profile for T2 Biosystems, Inc. (TTOO : OTC) |
|
|
| |
| • Company Description |
| T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.
Number of Employees: 113 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.11 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 110,361 shares |
| Shares Outstanding: 21.04 (millions) |
| Market Capitalization: $2.31 (millions) |
| Beta: 0.43 |
| 52 Week High: $0.26 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-19.65% |
-23.69% |
| 12 Week |
0.00% |
-12.90% |
| Year To Date |
-73.81% |
-75.54% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
John Sperzel - President; Chief Executive Officer and Chairman of
John Sprague - Chief Financial Officer
Michael Gibbs, Esq. - Senior Vice President and General Counsel
Laura Adams - Director
Robin Toft - Director
|
|
Peer Information
T2 Biosystems, Inc. (ABMD)
T2 Biosystems, Inc. (DMDS)
T2 Biosystems, Inc. (CPWY.)
T2 Biosystems, Inc. (EQUR)
T2 Biosystems, Inc. (ECIA)
T2 Biosystems, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 89853L302
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/24
Next Expected EPS Date: 08/04/25
|
|
Share - Related Items
Shares Outstanding: 21.04
Most Recent Split Date: 10.00 (0.01:1)
Beta: 0.43
Market Capitalization: $2.31 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/04/25 |
|
|
|
| |
